Gotham Asset Management LLC Purchases New Holdings in Encompass Health Co. (NYSE:EHC)

Gotham Asset Management LLC purchased a new stake in Encompass Health Co. (NYSE:EHC) in the fourth quarter, Holdings Channel.com reports. The firm purchased 5,469 shares of the company’s stock, valued at approximately $505,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of EHC. Vanguard Group Inc. grew its position in shares of Encompass Health by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock worth $960,817,000 after acquiring an additional 138,196 shares in the last quarter. Invesco Ltd. boosted its holdings in Encompass Health by 3.3% in the fourth quarter. Invesco Ltd. now owns 5,536,251 shares of the company’s stock worth $511,273,000 after purchasing an additional 176,135 shares during the period. Alliancebernstein L.P. boosted its holdings in Encompass Health by 6.0% in the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock worth $191,799,000 after purchasing an additional 117,617 shares during the period. FMR LLC boosted its holdings in Encompass Health by 0.8% in the fourth quarter. FMR LLC now owns 1,973,846 shares of the company’s stock worth $182,285,000 after purchasing an additional 15,831 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Encompass Health by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock worth $155,176,000 after buying an additional 6,164 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of the business’s stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the sale, the insider now owns 11,958 shares of the company’s stock, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John Patrick Darby sold 10,000 shares of the business’s stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the sale, the executive vice president now directly owns 79,710 shares in the company, valued at $9,149,910.90. This represents a 11.15% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders.

Encompass Health Trading Up 0.2%

Shares of NYSE EHC opened at $121.15 on Tuesday. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $121.44. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The company has a market cap of $12.21 billion, a price-to-earnings ratio of 27.16, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The stock’s 50 day simple moving average is $105.97 and its 200 day simple moving average is $100.90.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The firm’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.12 EPS. Equities research analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health’s payout ratio is currently 14.05%.

Wall Street Analyst Weigh In

EHC has been the topic of several research reports. Truist Financial reiterated a “buy” rating and set a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. KeyCorp raised their price target on Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a report on Friday, April 25th. Royal Bank of Canada raised their price target on Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a report on Monday, April 28th. Finally, UBS Group raised their price target on Encompass Health from $117.00 to $130.00 and gave the stock a “buy” rating in a report on Monday, April 28th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $120.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.